Role of NLRP3 signals in ischemia/reperfusion-induced organ injury

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3R01DK128547-02S1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021.0
    2026.0
  • Known Financial Commitments (USD)

    $924,366
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    PROFESSOR Dianne Mckay
  • Research Location

    United States of America
  • Lead Research Institution

    SCRIPPS RESEARCH INSTITUTE, THE
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Project Summary: This proposal evaluates how the cytoplasmic innate immune receptor, NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) contributes to chronic kidney disease (CKD) after SARS-CoV2 infection of human and murine kidneys. The project is highly significant for understanding the steps leading to chronic renal injury associated with COVID-19 disease. Broad/long-term objectives: The long-term goals of the proposed research are to define how activation of NLRP3 contributes to chronic injurious tissue responses in human kidneys following SARS-CoV2 infection. Specific Aims: The central goal of this proposal is to test the hypothesis that SARS-CoV2 infection triggers cell- type specific responses that affect the NLRP3 pathway, and that dysregulation of this pathway contributes to the pathogenesis of CKD as a post-acute sequalae of COVID-19 disease. Research Design and Methods for Achieving the Stated Goals: Aim 1 will examine the effect of SARS-CoV2 infection on NLRP3 pathway activation and its functional consequences in human and murine renal tubular epithelia and will test consequences of blockade. Aim 2 will examine how SARS-CoV2 infection induces chronic kidney injury using two murine models of infection, and tests whether blockade of NLRP3 signaling pathways prevents that injury. Aim 3 will examine the consequences of NLRP3 pathway activation and blockade in SARS-CoV2 chronically infected human kidney organoids. Health Relatedness of Project: If the aims of this proposal are met we will learn how activation of NLRP3 contributes to the pathogenesis of the post-acute sequalae of CKD after COVID-19 disease. This knowledge is crucial for the development of rational target therapies for prevention or amelioration of organ injury following SARS- CoV2 infection.